Tomato |
J Nutr Biochem. 2009 Jun;20(6):426-34. Epub 2008 Aug 15.
Concomitant supplementation of lycopene and eicosapentaenoic acid inhibits the proliferation of human colon cancer cells.
Tang FY, Cho HJ, Pai MH, Chen YH.
Biomedical Science Laboratory, Department of Nutrition, China Medical University, Taichung 40402, Taiwan. [email protected]
Several studies indicated that people who live in the Mediterranean region have very low rates of chronic diseases such as cardiovascular disease and cancer. It is well known that Mediterranean-style diet is rich in vegetables, tomato, fruit, fish and olive oil. These important dietary components may contribute to lower risk of cancer. Lycopene, a major component in tomato, exhibited potential anticarcinogenic activity. Previous studies showed that consumption of fish containing eicosapentaenoic acid (EPA) correlated with reduced risk of cancer. However, the combined effects of lycopene and EPA on the proliferation of human colon cancer have not been studied well yet. Thus, we investigated the anticancer properties and therapeutic potential of lycopene and EPA in human colon cancer HT-29 cells. In this study, we determined the combined effects of lycopene and EPA on the proliferation of human colon cancer HT-29 cells. We demonstrated http://www.ncbi.nlm.nih.gov/pubmed/18708285
Food Chem Toxicol. 2008 Dec;46(12):3612-5. Epub 2008 Sep 11.
Effects of tomato extract on oxidative stress induced toxicity in different organs of rats.
Jamshidzadeh A, Baghban M, Azarpira N, Bardbori AM, Niknahad H.
Department of Pharmacology and Toxicology, Shiraz University of Medical Sciences, Shiraz, Fars 71345-1583, Iran.
Tomato products containing lycopene are believed to be associated with decreased risk of chronic diseases including cancer, and its effects are suggested to be due to antioxidant effect of lycopene. The aim of this research was to study the effects of tomato extract on acetaminophen (APAP), amiodarone (ADN) and cyclosporine A (CsA)-induced liver, lung and kidney toxicity, respectively. Previous studies have shown that free radical reactions may play important roles in toxicity of these drugs. Rats received a single dose of APAP (750mg/kg, i.p.) before treatment with tomato extract (5mg/kg, oral) for seven consecutive days, ADN (100mg/kg, i.p.) plus tomato extract (5mg/kg, oral) for 10 consecutive days, or CsA (250mg/kg, i.p.) plus tomato extract (5mg/kg, oral) for 14 consecutive days. At the end of each treatment, the animals were sacrificed and the related organ tissues were collected for biochemical and histopathological examinations. Simultaneous treatment of tomato extract ameliorated tissue damage, biochemical indices, and oxidative stress parameters against APAP-induced acute hepatotoxicity, but had less beneficial effects on ADN-induced lung toxicity and little effect against CsA-induced nephrotoxicity. Therefore, tomato products may be beneficial for the prevention and therapy of toxicity induced by ADN and APAP.
Source: PubMed
http://www.ncbi.nlm.nih.gov/pubmed/18834914
J Am Coll Nutr. 2000 Oct;19(5):563-9.
Role of antioxidant lycopene in cancer and heart disease.
Rao AV, Agarwal S.
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Ontario, Canada. [email protected]
Lycopene, a carotenoid without provitamin-A activity, is present in many fruits and vegetables; however, tomatoes and processed tomato products constitute the major source of lycopene in North American diet. Among the carotenoids, lycopene is a major component found in the serum and other tissues. Dietary intakes of tomatoes and tomato products containing lycopene have been shown to be associated with decreased risk of chronic diseases such as cancer and cardiovascular diseases in several recent studies. Serum and tissue lycopene levels have also been inversely related with the chronic disease risk. Although the antioxidant properties of lycopene are thought to be primarily responsible for its beneficial properties, evidence is accumulating to suggest other mechanisms such as modulation of intercellular gap junction communication, hormonal and immune system and metabolic pathways may also be involved….
Source: PubMed
http://www.ncbi.nlm.nih.gov/pubmed/11022869
Aktuelle Urol. 2009 Jan;40(1):37-43. Epub 2009 Jan 28.
[Tomatoes and lycopene in prevention and therapy--is there an evidence for prostate diseases?]
[Original Article in German]
Ellinger S, Ellinger J, Müller SC, Stehle P.
Institut für Ernährungs- und Lebensmittelwissenschaften, Fachbereich Ernährungsphysiologie, Universität Bonn, Bonn. [email protected]
Tomatoes are discussed to have an important role in the prevention of and therapy for prostate cancer (PCA). Whether or not they are also useful in the primary and secondary prevention of benign prostate hyperplasia (BPH) is not clear. This review summarises the results of original contributions with a focus on interventional studies. Whereas epidemiological studies on BPH prevention provide no evidence for a preventive potential of tomatoes and tomato products, the majority of interventional trials points to an increased DNA resistance against oxidative-induced damage. Even though their effect on a surrogate marker of the IGF pathway cannot be evaluated so far due to insufficient data, the consumption of tomatoes and tomato products may probably protect from PCA--at least when considering low-grade PCA. Thus, regular consumption of these foods can be recommended for the prevention of PCA. Tomato products might also be useful in the therapy for BPH and PCA. The intake of isolated lycopene does not protect from the development of PCA. However, in the doses achieved by consumption of tomato products, lycopene ingestion might also be effective in PCA therapy.
Source: PubMed